文献速递瓣膜外科

梗阻性肥厚型心肌病中的二尖瓣环钙化:患病率与结局

Mitral Annular Calcification in Obstructive Hypertrophic Cardiomyopathy: Prevalence and Outcomes.
PubMed 文献 · Ann Thorac Surg · 2021-11-22

该研究回顾了2000年1月至2016年4月接受室间隔心肌切除术的2113例梗阻性肥厚型心肌病患者,发现二尖瓣环钙化(MAC)患病率为18.5%(390例)。MAC与高龄、女性和二尖瓣叶钙化相关,并增加同期二尖瓣置换率(6% vs 1%)。中位随访6.95年后,MAC是术后远期生存的独立不良预测因素(HR 1.46)。

要点

  • 梗阻性肥厚型心肌病患者中MAC患病率为18.5%。
  • MAC患者同期二尖瓣置换率更高(6% vs 1%,P < .001)。
  • MAC是室间隔心肌切除术后远期死亡的独立预测因素(HR 1.46)。

核心结论

  • MAC在老年梗阻性肥厚型心肌病患者中常见,女性更易见,与更高的同期二尖瓣置换率相关。
  • 尽管合并症患病率更高,MAC仍是室间隔心肌切除术后全因死亡的独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月至2016年4月期间接受室间隔心肌切除术的2113例梗阻性肥厚型心肌病患者。
  • 通过复习术前和术中超声心动图及手术记录识别MAC。
  • 采用Kaplan-Meier分析和log-rank检验估计并比较生存率,采用Cox回归分析识别与死亡率独立相关的因素。

主要发现

  • 390例(18.5%)患者检出MAC。
  • 高龄、女性和存在二尖瓣叶钙化与MAC患病几率增高强烈相关。
  • MAC患者静息左心室流出道压差更高,术前二尖瓣反流更严重,同期二尖瓣置换率更高(6% vs 1%;P < .001)。
  • 术后MAC患者残余二尖瓣反流略高(13% vs 8%)。
  • 中位随访6.95年(四分位距3.7-12.1年),MAC患者1年、5年和10年生存率分别为99%、92%和69%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence and clinical impact of mitral annular calcification (MAC) in patients with obstructive hypertrophic cardiomyopathy (HCM) are largely unknown. METHODS: We reviewed 2113 HCM patients who underwent septal myectomy from January 2000 to April 2016. Preoperative and intraoperative echocardiograms along with operative notes were reviewed to identify MAC. Survival was estimated and compared using Kaplan-Meier analysis and the log-rank test. Cox regression analysis was used to identify factors independently associated with mortality. RESULTS: MAC was identified in 390 (18.5%) patients. Older age, female sex, and presence of mitral valve leaflet calcification were strongly associated with higher odds of having MAC. Patients with MAC had higher resting left ventricular outflow tract gradients, were more likely to have worse mitral regurgitation preoperatively, and were more likely to undergo a concomitant mitral valve replacement (6% vs 1%; P < .001) compared with those without MAC. Postoperatively, patients with MAC had marginally higher residual mitral regurgitation (13% vs 8%). After a median follow-up of 6.95 (interquartile range, 3.7-12.1) years, survival of patients with MAC at 1, 5, and 10 years was 99%, 92%, and 69%, respectively. Adjusted analysis identified MAC as an independent predictor of poor survival (hazard ratio, 1.46; 95% confidence interval, 1.08-1.97; P = .014). CONCLUSIONS: MAC is a frequent finding in older patients with obstructive HCM, is more likely to be seen in females, and is associated with higher rates of concomitant mitral valve replacement. Despite the higher prevalence of comorbidities, MAC remained an independent predictor for overall mortality after septal myectomy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Patlolla SH, Schaff HV, Nishimura RA, et al. Mitral Annular Calcification in Obstructive Hypertrophic Cardiomyopathy: Prevalence and Outcomes. Ann Thorac Surg. 2021. PMID: 34822847. doi:10.1016/j.athoracsur.2021.09.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。